Calamos Advisors’s Cabot Corp CBT Stock Holding History

Calamos Advisors’s Portfolio CBT Stock Details CBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,609	Closed	-$550K	–	1247
2022 Q3	$550K	Buy	+8,609	New	+$607K	﹤0.01%	1004

Other funds holding CBT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Calamos Advisors's CBT Position: Q4 2022 in Review

Calamos Advisors sold out of Cabot Corp (CBT) in Q4 2022, closing a stake of 8,609 shares — an estimated $550K sold.

Calamos Advisors first reported a position in CBT in Q3 2022 and held it in 1 quarter. The position peaked at $550K in Q3 2022. 316 funds tracked by Wall St. Rank hold CBT as of Q4 2022.

Calamos Advisors reported no remaining Cabot Corp position as of Q4 2022 after selling out during the quarter.
Calamos Advisors sold 8,609 Cabot Corp shares in Q4 2022, an estimated $550K.
Calamos Advisors first reported a position in Cabot Corp in Q3 2022 and held it in 1 quarter.
Calamos Advisors's Cabot Corp position peaked at $550K in Q3 2022.
316 funds tracked by Wall St. Rank held Cabot Corp as of Q4 2022.

Based on Calamos Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.